NR577 2026 CERTIFICATION SCRIPT FULL
QUESTIONS AND CORRECT ANSWERS
◉2. A patient with absence seizures is mistakenly started on
carbamazepine. What is the most likely outcome? A. Improved
seizure control B. No clinical change C. Worsening seizure frequency
D. Conversion to focal seizures. Answer: C. Worsening seizure
frequency
◉3. A patient with migraine headaches and coronary artery disease
should avoid which medication? A. Propranolol B. Topiramate C.
Sumatriptan D. Amitriptyline. Answer: C. Sumatriptan
◉4. A patient with type 2 diabetes and recurrent hypoglycemia
should avoid which medication class? A. GLP-1 receptor agonists B.
SGLT2 inhibitors C. Metformin D. Sulfonylureas. Answer: D.
Sulfonylureas
◉5. Which diabetes medication provides cardiovascular benefit and
weight loss? A. Sulfonylurea B. Insulin C. GLP-1 receptor agonist D.
TZD. Answer: C. GLP-1 receptor agonist
QUESTIONS AND CORRECT ANSWERS
◉2. A patient with absence seizures is mistakenly started on
carbamazepine. What is the most likely outcome? A. Improved
seizure control B. No clinical change C. Worsening seizure frequency
D. Conversion to focal seizures. Answer: C. Worsening seizure
frequency
◉3. A patient with migraine headaches and coronary artery disease
should avoid which medication? A. Propranolol B. Topiramate C.
Sumatriptan D. Amitriptyline. Answer: C. Sumatriptan
◉4. A patient with type 2 diabetes and recurrent hypoglycemia
should avoid which medication class? A. GLP-1 receptor agonists B.
SGLT2 inhibitors C. Metformin D. Sulfonylureas. Answer: D.
Sulfonylureas
◉5. Which diabetes medication provides cardiovascular benefit and
weight loss? A. Sulfonylurea B. Insulin C. GLP-1 receptor agonist D.
TZD. Answer: C. GLP-1 receptor agonist